378 related articles for article (PubMed ID: 18789542)
1. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
[TBL] [Abstract][Full Text] [Related]
2. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
[TBL] [Abstract][Full Text] [Related]
3. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
4. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
[TBL] [Abstract][Full Text] [Related]
5. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
7. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage.
Sioud M; Fløisand Y; Forfang L; Lund-Johansen F
J Mol Biol; 2006 Dec; 364(5):945-54. PubMed ID: 17049554
[TBL] [Abstract][Full Text] [Related]
8. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G
J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
10. Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8.
Lan T; Putta MR; Wang D; Dai M; Yu D; Kandimalla ER; Agrawal S
Biochem Biophys Res Commun; 2009 Aug; 386(3):443-8. PubMed ID: 19523922
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
[TBL] [Abstract][Full Text] [Related]
12. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats.
Hammerbeck DM; Burleson GR; Schuller CJ; Vasilakos JP; Tomai M; Egging E; Cochran FR; Woulfe S; Miller RL
Antiviral Res; 2007 Jan; 73(1):1-11. PubMed ID: 16959331
[TBL] [Abstract][Full Text] [Related]
13. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
14. Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8.
Lan T; Bhagat L; Wang D; Dai M; Kandimalla ER; Agrawal S
Bioorg Med Chem Lett; 2009 Apr; 19(7):2044-7. PubMed ID: 19269175
[TBL] [Abstract][Full Text] [Related]
15. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation.
Dillon SM; Rogers LM; Howe R; Hostetler LA; Buhrman J; McCarter MD; Wilson CC
J Immunol; 2010 Jun; 184(12):6612-21. PubMed ID: 20483758
[TBL] [Abstract][Full Text] [Related]
16. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.
Löseke S; Grage-Griebenow E; Heine H; Wagner A; Akira S; Bauer S; Bufe A
Scand J Immunol; 2006 Apr; 63(4):264-74. PubMed ID: 16623926
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
[TBL] [Abstract][Full Text] [Related]
18. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
[TBL] [Abstract][Full Text] [Related]
19. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
[TBL] [Abstract][Full Text] [Related]
20. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
Smits EL; Cools N; Lion E; Van Camp K; Ponsaerts P; Berneman ZN; Van Tendeloo VF
Cancer Immunol Immunother; 2010 Jan; 59(1):35-46. PubMed ID: 19449004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
